Evidence map›Paper›PMID 27328692›Full record

ArticleParticle and fibre toxicology2016

Evaluation of pulmonary and systemic toxicity following lung exposure to graphite nanoplates: a member of the graphene-based nanomaterial family.

Jenny R Roberts, Robert R Mercer, Aleksandr B Stefaniak, Mohindar S Seehra, Usha K Geddam, Ishrat S Chaudhuri, Angelos Kyrlidis, Vamsi K Kodali, Tina Sager, Allison Kenyon and 11 more

Open access · goldAbstract read
In one paragraph

Article in Particle and fibre toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Graphene Oxide Normal (GO + MnAntioxidants (Basel, Switzerland) · 2021
    Article
  17. Size-Dependent Pulmonary Impact of Thin Graphene Oxide Sheets in Mice: Toward Safe-by-Design.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Article
  18. Review
  19. The asbestos-carbon nanotube analogy: An update.Toxicology and applied pharmacology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Jenny R RobertsNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA. jur6@cdc.gov.
Robert R MercerNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Aleksandr B StefaniakNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Mohindar S SeehraWest Virginia University, Morgantown, WV, 26505, USA.
Usha K GeddamWest Virginia University, Morgantown, WV, 26505, USA.
Ishrat S ChaudhuriCabot Corporation, Billerica, MA, 01821, USA.
Angelos KyrlidisCabot Corporation, Billerica, MA, 01821, USA.
Vamsi K KodaliNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Tina SagerNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Allison KenyonNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Suzan A BilgesuNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Tracy EyeNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
James F ScabilloniNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Stephen S LeonardNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Natalie R FixNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Diane Schwegler-BerryNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Breanne Y FarrisWest Virginia University, Morgantown, WV, 26505, USA.
Michael G WolfarthNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Dale W PorterNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
Vincent CastranovaWest Virginia University, Morgantown, WV, 26505, USA.
Aaron ErdelyNational Institute for Occupational Safety and Health, CDC/NIOSH/HELD, 1095 Willowdale Rd., MS4020, Morgantown, WV, 26505, USA.
National Institute for Occupational Safety and Health · USWest Virginia University · USCabot (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGraphene, a monolayer of carbon, is an engineered nanomaterial (ENM) with physical and chemical properties that may offer application advantages over other carbonaceous ENMs, such as carbon nanotubes (CNT). The goal of this study was to comparatively assess pulmonary and systemic toxicity of graphite nanoplates, a member of the graphene-based nanomaterial family, with respect to nanoplate size.

methodsThree sizes of graphite nanoplates [20 μm lateral (Gr20), 5 μm lateral (Gr5), and <2 μm lateral (Gr1)] ranging from 8-25 nm in thickness were characterized for difference in surface area, structure,, zeta potential, and agglomeration in dispersion medium, the vehicle for in vivo studies. Mice were exposed by pharyngeal aspiration to these 3 sizes of graphite nanoplates at doses of 4 or 40 μg/mouse, or to carbon black (CB) as a carbonaceous control material. At 4 h, 1 day, 7 days, 1 month, and 2 months post-exposure, bronchoalveolar lavage was performed to collect fluid and cells for analysis of lung injury and inflammation. Particle clearance, histopathology and gene expression in lung tissue were evaluated. In addition, protein levels and gene expression were measured in blood, heart, aorta and liver to assess systemic responses.

resultsAll Gr samples were found to be similarly composed of two graphite structures and agglomerated to varying degrees in DM in proportion to the lateral dimension. Surface area for Gr1 was approximately 7-fold greater than Gr5 and Gr20, but was less reactive reactive per m(2). At the low dose, none of the Gr materials induced toxicity. At the high dose, Gr20 and Gr5 exposure increased indices of lung inflammation and injury in lavage fluid and tissue gene expression to a greater degree and duration than Gr1 and CB. Gr5 and Gr20 showed no or minimal lung epithelial hypertrophy and hyperplasia, and no development of fibrosis by 2 months post-exposure. In addition, the aorta and liver inflammatory and acute phase genes were transiently elevated in Gr5 and Gr20, relative to Gr1.

conclusionsPulmonary and systemic toxicity of graphite nanoplates may be dependent on lateral size and/or surface reactivity, with the graphite nanoplates > 5 μm laterally inducing greater toxicity which peaked at the early time points post-exposure relative to the 1-2 μm graphite nanoplate.

Indexed as

NanoparticlesAnimalsBronchoalveolar Lavage FluidGraphiteLungMiceMicroscopy, Electron, ScanningNanostructuresRNA, MessengerGraphiteRNA, MessengerCardiovascular toxicityGraphene-based nanomaterialsLung toxicityParticle sizePulmonary exposure

Identifiers

PMID27328692
PMCPMC4915050
OpenAlexW2474403182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.